You can’t stop treating people while we research for a cure.
And in fact both already do happen in parallel. So your point is moot.
And in fact both already do happen in parallel. So your point is moot.
“Cumulatively between 2023 and 2050, it will cost nearly $18 trillion (in 2023 dollars) — nearly two-thirds of which will be borne by Medicare and Medicaid.”
https://alzimpact.org/sites/default/files/2023-03/Fiscal%20Y...
So, my not so moot point is we are not spending nearly enough on research.
Also, note that this investment money is directly related to the number of working hours. All those people working on a cure in labs etc. will have a very different experience in life compared to those same people earning the same money for caring for their fellow humans. It is not a purely financial weighing.